•Reported net sales of $328 million, down 19.7% compared with the second quarter of 2024

•Delivered gross profit margin of 59.1%, flat versus the prior year

•Reduced second quarter operating expenses by $48 million, or 21%, year-over-year, before restructuring and other non-recurring costs

•Reported net loss of $25 million, inclusive of a $13 million adjustment to valuation of deferred tax assets, compared to a net loss of $5 million for the same period last year

•Delivered adjusted EBITDA of $24 million, down 17% versus the same period last year

•Implementing $130 million of cost savings for 2025, exceeding prior annualized target of $80 million to $100 million, before restructuring and other non-recurring costs; maintains compliance with debt covenants

MINNEAPOLIS – (July 30, 2025) – Sleep Number Corporation (Nasdaq: SNBR) today reported results for the quarter ended June 28, 2025.

Linda Findley, President and CEO, commented, “Sleep Number is in a turnaround. I joined because it is fundamentally a great company and I continue to believe that. In my first 100 days, the new leadership team has been focused on digging into our product and consumer proposition. It is clear Sleep Number has a strong brand and differentiated products. We are building on these core strengths with plans to return to profitable growth by starting to implement initiatives focused on enhancing our product assortment, value proposition, and consumer engagement.

"At the start of the second quarter, we aggressively reduced expenses to reset our cost structure, and ensure ongoing compliance with our debt covenants. We cut marketing spend dramatically in Q2 because the old marketing strategy was inefficient, and we needed to implement a major reset. We expected the sharp drop in second quarter sales based on these changes. We are rebuilding this program and are already seeing signs that our new, more efficient approach is working. In parallel, we are also working to optimize our product portfolio, value and distribution, with the goal of focusing on the products, price points and benefits that matter most to our customers.

"We are energized by the work ahead and have created the right environment, with the right team, for Sleep Number to thrive. We have proven our ability to manage costs and improve efficiency. Although our topline remains pressured, we expect our actions to drive sequential topline improvement in the coming quarters while we continue to aggressively manage our costs."

Second Quarter Overview (all comparisons year-over-year unless otherwise noted)

•Net sales of $328 million were down 19.7%, driven by lower volume and a reduced store count.

•Gross profit was $194 million, a decrease of $48 million. Gross profit margin of 59.1% was consistent with the prior year.

•Operating expenses were $185 million before restructuring and other non-recurring costs, a decrease of $48 million, or 21%, driven by lower marketing and selling expenses, general and administrative expenses, and research and development expenses.

•Net loss was $25 million or $1.09 per diluted share, down $20 million, driven primarily by lower net sales, partially offset by lower operating expenses.

•Adjusted EBITDA was $24 million, down 17%, driven by a decline in net sales and associated loss of fixed cost leverage, partially offset by lower operating expenses. Adjusted EBITDA margin improved 30 basis points to 7.2%.

Cash Flows, Liquidity and Balance Sheet Highlights (all comparisons year-over-year unless otherwise noted)

•Net cash provided by operating activities was $1.2 million for the quarter, down $22 million.

•Free cash flow was a use of $6.9 million for the quarter, down $16 million.

•The company's leverage ratio was 4.56x EBITDAR on a trailing 12-month basis at the end of the quarter versus the covenant maximum of 4.75x.

The company expects the full year 2025 net sales to be approximately $1.45 billion, representing an approximately 14% year-over-year decline. This percentage change is partly driven by softer year-over-year comparisons and the 53rd week in 2025. Gross profit margin is expected to be 61%, which is consistent with the first quarter of 2025, and full year operating expenses, excluding restructuring and other non-recurring costs, are expected to be approximately $830 million. The company expects break-even free cash flow in the second half of 2025.

Management will host its regularly scheduled conference call to discuss the company’s results at 8:30 a.m. EDT (7:30 a.m. CDT; 5:30 a.m. PDT) today. To access the webcast, please visit the investor relations area of the Sleep Number website at https://ir.sleepnumber.com. The webcast replay will remain available for approximately 60 days.

Sleep Number is a sleep wellness company. We are guided by our purpose to improve the health and wellbeing of society through higher quality sleep; to date, our innovations have improved nearly 16 million lives. Our sleep wellness platform helps solve sleep problems, whether it’s providing individualized temperature control for each sleeper through our Climate360® smart bed or applying our 34 billion hours of longitudinal sleep data and expertise to research with global institutions. Our smart bed ecosystem drives best-in-class engagement through dynamic, adjustable, and effortless sleep with personalized sleep and health insights; our millions of Smart Sleepers are loyal brand advocates. And our 3,400 mission-driven team members passionately innovate to drive value creation through our vertically integrated business model, including our exclusive direct-to-consumer selling in 630 stores and online.

To learn more about life-changing, individualized sleep, visit a Sleep Number® store near you, our newsroom and investor relations sites, or SleepNumber.com.

Statements used in this news release relating to future plans, events, financial results or performance, such as the statements that: cost savings to exceed initial targets while maintaining compliance with debt covenants; implementing significant changes to business with enhanced marketing and product initiatives; implementing $130 million of cost savings for 2025 excluding restructuring costs that maintains compliance with debt covenants; plans to return to profitable growth by implementing initiatives focused on enhancing the company's product assortment, value proposition, and consumer engagement; rebuilding the marketing program for efficiency and optimizing its product portfolio, value and distribution; the company has proven its ability to manage costs and improve efficiency; the company expects its actions to drive sequential topline improvement in the coming quarters while it continues to aggressively manage costs; and statements about the company’s financial outlook, including the company’s expected full year 2025 net sales, gross profit margin, and operating expenses, excluding restructuring and other non-recurring costs, and free cash flow expectations in the second half of 2025 are forward-looking statements subject to certain risks and uncertainties which could cause the company’s results to differ materially. The most important risks and uncertainties are described in the company’s filings with the Securities and Exchange Commission, including in Item 1A of the company’s Annual Report on Form 10-K and other periodic reports. Forward-looking statements speak only as of the date they are made, and the company does not undertake any obligation to update any forward-looking statement.

Investor Contact: investorrelations@sleepnumber.com

Media Contact: Muriel Lussier, muriel.lussier@sleepnumber.com

 

			Three Months Ended
			June 28, 2025						% of Net Sales						June 29, 2024						% of Net Sales
Net sales			$	327,925					100.0		%				$	408,413					100.0		%
Cost of sales			134,180						40.9		%				166,923						40.9		%
Gross profit			193,745						59.1		%				241,490						59.1		%
Operating expenses:
Sales and marketing			146,464						44.7		%				182,400						44.7		%
General and administrative			29,604						9.0		%				39,573						9.7		%
Research and development			9,420						2.9		%				11,578						2.8		%
Restructuring costs			8,332						2.5		%				1,819						0.4		%
Total operating expenses			193,820						59.1		%				235,370						57.6		%
Operating (loss) income			(75)						—		%				6,120						1.5		%
Interest expense, net			11,734						3.6		%				12,270						3.0		%
Loss before income taxes			(11,809)						(3.6		%)				(6,150)						(1.5		%)
Income tax expense (benefit)			13,203						4.0		%				(1,099)						(0.3		%)
Net loss			$	(25,012)					(7.6		%)				$	(5,051)					(1.2		%)
Net loss per share – basic			$	(1.09)											$	(0.22)
Net loss per share – diluted			$	(1.09)											$	(0.22)
Reconciliation of weighted-average shares outstanding:
Basic weighted-average shares outstanding			22,903												22,614
Dilutive effect of stock-based awards			—												—
Diluted weighted-average shares outstanding			22,903												22,614

For the three months ended June 28, 2025 and June 29, 2024, potentially dilutive stock-based awards have been excluded from the calculation of diluted weighted-average shares outstanding, as their inclusion would have had an anti-dilutive effect on our net loss per diluted share.

 

			Six Months Ended
			June 28, 2025						% of Net Sales						June 29, 2024						% of Net Sales
Net sales			$	721,186					100.0		%				$	878,862					100.0		%
Cost of sales			286,906						39.8		%				361,198						41.1		%
Gross profit			434,280						60.2		%				517,664						58.9		%
Operating expenses:
Sales and marketing			335,567						46.5		%				390,912						44.5		%
General and administrative			68,223						9.5		%				78,652						8.9		%
Research and development			20,323						2.8		%				24,019						2.7		%
Restructuring costs			8,392						1.2		%				12,419						1.4		%
Total operating expenses			432,505						60.0		%				506,002						57.6		%
Operating income			1,775						0.2		%				11,662						1.3		%
Interest expense, net			22,815						3.2		%				24,569						2.8		%
Loss before income taxes			(21,040)						(2.9		%)				(12,907)						(1.5		%)
Income tax expense (benefit)			12,618						1.7		%				(374)						—		%
Net loss			$	(33,658)					(4.7		%)				$	(12,533)					(1.4		%)
Net loss per share – basic			$	(1.48)											$	(0.56)
Net loss per share – diluted			$	(1.48)											$	(0.56)
Reconciliation of weighted-average shares outstanding:
Basic weighted-average shares outstanding			22,804												22,560
Dilutive effect of stock-based awards			—												—
Diluted weighted-average shares outstanding			22,804												22,560

For the six months ended June 28, 2025 and June 29, 2024, potentially dilutive stock-based awards have been excluded from the calculation of diluted weighted-average shares outstanding, as their inclusion would have had an anti-dilutive effect on our net loss per diluted share.

  

			June 28, 2025						December 28, 2024
Assets
Current assets:
Cash and cash equivalents			$	1,349					$	1,950
Accounts receivable, net of allowances of $1,127 and $1,113, respectively			16,017						17,516
Inventories			99,450						103,152
Prepaid expenses			20,824						14,568
Other current assets			37,885						44,098
Total current assets			175,525						181,284
Non-current assets:
Property and equipment, net			109,105						129,574
Operating lease right-of-use assets			339,149						356,641
Goodwill and intangible assets, net			66,301						66,412
Deferred income taxes			31,803						33,575
Other non-current assets			82,629						93,324
Total assets			$	804,512					$	860,810
Liabilities and Shareholders’ Deficit
Current liabilities:
Borrowings under revolving credit facility			$	563,900					$	546,600
Accounts payable			111,212						107,619
Customer prepayments			41,141						46,933
Accrued sales returns			15,650						19,092
Compensation and benefits			20,929						31,038
Taxes and withholding			17,854						18,619
Operating lease liabilities			82,209						82,307
Other current liabilities			50,326						55,804
Total current liabilities			903,221						908,012
Non-current liabilities:
Operating lease liabilities			287,585						307,201
Other non-current liabilities			94,394						97,183
Total non-current liabilities			381,979						404,384
Total liabilities			1,285,200						1,312,396
Shareholders’ deficit:
Undesignated preferred stock; 5,000 shares authorized, no shares issued and outstanding			—						—
Common stock, $0.01 par value; 142,500 shares authorized, 22,771 and 22,388 shares issued and outstanding, respectively			228						224
Additional paid-in capital			31,942						27,390
Accumulated deficit			(512,858)						(479,200)
Total shareholders’ deficit			(480,688)						(451,586)
Total liabilities and shareholders’ deficit			$	804,512					$	860,810

 

			Six Months Ended
			June 28, 2025						June 29, 2024
Cash flows from operating activities:
Net loss			$	(33,658)					$	(12,533)
Adjustments to reconcile net loss to net cash provided by    operating activities:
Depreciation and amortization			29,096						34,177
Stock-based compensation			5,500						8,109
Net loss on disposals and impairments of assets			775						2,500
Deferred income taxes			1,772						(5,144)
Changes in operating assets and liabilities:
Accounts receivable			1,499						6,587
Inventories			3,702						19,588
Income taxes			2,470						774
Prepaid expenses and other assets			10,381						(1,483)
Accounts payable			8,354						(18,464)
Customer prepayments			(5,792)						(4,625)
Accrued compensation and benefits			(10,086)						7,153
Other taxes and withholding			(3,235)						(1,345)
Other accruals and liabilities			(9,582)						(11,776)
Net cash provided by operating activities			1,196						23,518
Cash flows from investing activities:
Purchases of property and equipment			(8,052)						(14,075)
Payment to secure contractual rights			(3,280)						—
Issuance of notes receivable			—						(2,942)
Net cash used in investing activities			(11,332)						(17,017)
Cash flows from financing activities:
Net increase (decrease) in short-term borrowings			12,356						(6,408)
Repurchases of common stock			(944)						(612)
Debt issuance costs			(1,877)						—
Net cash provided by (used in) financing activities			9,535						(7,020)
Net decrease in cash and cash equivalents			(601)						(519)
Cash and cash equivalents, at beginning of period			1,950						2,539
Cash and cash equivalents, at end of period			$	1,349					$	2,020

 

			Three Months Ended												Six Months Ended
			June 28, 2025						June 29, 2024						June 28, 2025						June 29, 2024
Percent of sales:
Retail stores			87.8		%				87.8		%				87.7		%				88.0		%
Online, phone, chat and other			12.2		%				12.2		%				12.3		%				12.0		%
Total Company			100.0		%				100.0		%				100.0		%				100.0		%
Sales change rates:
Retail comparable-store sales			(18		%)				(11		%)				(17		%)				(10		%)
Online, phone and chat			(19		%)				(13		%)				(16		%)				(16		%)
Total Retail comparable sales change			(19		%)				(11		%)				(17		%)				(11		%)
Net opened/closed stores and other			(1		%)				0		%				(1		%)				—		%
Total Company			(20		%)				(11		%)				(18		%)				(11		%)
Stores open:
Beginning of period			637						661						640						672
Opened			1						4						3						10
Closed			(8)						(19)						(13)						(36)
End of period			630						646						630						646
Other metrics:
Average sales per store ($ in 000's) 1			$	2,395					$	2,732
Average sales per square foot 1			$	775					$	883
Stores > $2 million net sales 2			47		%				62		%
Stores > $3 million net sales 2			13		%				21		%
Average revenue per smart bed unit 3			$	5,880					$	5,802					$	5,940					$	5,782

1 Trailing twelve months Total Retail comparable sales per store open at least one year.

2 Trailing twelve months for stores open at least one year (excludes online, phone and chat sales).

3 Represents Total Retail (stores, online, phone and chat) net sales divided by Total Retail smart bed units.

We define earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net loss plus: income tax expense (benefit), interest expense, depreciation and amortization, stock-based compensation, restructuring costs, CEO transition/proxy contest costs, and asset impairments. Management believes Adjusted EBITDA is a useful indicator of our financial performance and our ability to generate cash from operating activities. Our definition of Adjusted EBITDA may not be comparable to similarly titled definitions used by other companies. The table below reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable GAAP financial measure:

			Three Months Ended												Trailing Twelve Months Ended
			June 28, 2025						June 29, 2024						June 28, 2025						June 29, 2024
Net loss			$	(25,012)					$	(5,051)					$	(41,459)					$	(40,039)
Income tax expense (benefit)			13,203						(1,099)						7,830						(10,730)
Interest expense			11,734						12,270						46,614						48,214
Depreciation and amortization			13,697						16,347						59,590						69,676
Stock-based compensation			1,549						3,992						8,835						13,073
Restructuring costs 1			8,332						1,819						14,039						28,147
CEO transition/Proxy contest costs 2			53						—						2,825						—
Asset impairments			—						—						1,220						490
Adjusted EBITDA			$	23,556					$	28,278					$	99,494					$	108,831

1 Represents costs related to business restructuring actions initiated in the fourth quarter of fiscal 2023.

2 Represents costs related to CEO transition activities and proxy contest costs of $0.1 million and $0, respectively, for the three months ended June 28, 2025 and $0.8 million and $2.0 million, respectively, for the trailing twelve months ended June 28, 2025. These costs were both initiated in the fourth quarter of fiscal 2024.

 

Note - Our Adjusted EBITDA calculations and Free Cash Flow data are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.

1Reflects operating lease liabilities included in our financial statements under ASC 842.

Note - Our Net Leverage Ratio under Revolving Credit Facility, Adjusted EBITDA and EBITDAR calculations are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.

 

Adjusted ROIC is a financial measure we use to determine how efficiently we deploy our capital. It quantifies the return we earn on our adjusted invested capital. Management believes Adjusted ROIC is also a useful metric for investors and financial analysts. We compute Adjusted ROIC as outlined below. Our definition and calculation of Adjusted ROIC may not be comparable to similarly titled definitions and calculations used by other companies. The tables below reconcile adjusted net operating profit after taxes (Adjusted NOPAT) and total adjusted invested capital, which are non-GAAP financial measures, to the comparable GAAP financial measures: